This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Watch Citigroup, banking shares going forward after Citi's capital plan was rejected

James Dennin, Kapitall: When Citigroup failed its Fed stress test, banking shares were stressed out.

The rejection of Citigroup’s (C) capital plan not only surprised Citi’s executives but also hurt shareholders. With shares down nearly 10% in the quarter, should a lack of a dividend raise or share buyback deter investors?

The Federal Reserve said the capital plan “reflected a number of deficiencies in its capital planning practices, including in some areas that had been previously identified by supervisors as requiring attention, but for which there was not sufficient improvement.” The Fed wanted to see improvements in such things as Citi’s stress tests.

Read more analysis from Kapitall on Citigroup.

Investors will not see the dividend increase to five cents or a $4 billion share buyback. Despite the setback, investors should not assume Citi’s capital is in any trouble. If anything, Citi will need to revamp its capital controls so that it is ready for any stocks in the market.

Citi shares could revisit yearly lows, but its shares are already valued at the lowest in terms of price of profit (POP).

Only JPMorgan Chase (JPM) is valued comparably with Citi, with a POP of 10.

Unsurprisingly, Citi shares were downgraded by some firms. Bernstein and KBW both downgraded Citi shares after the capital plan was rejected. Citi now has a price to book ratio of 0.7 times and a P/E of 10.7. Its book value per share is $65.26.

Citi is underperforming compared to Bank of America (BAC) and JPMorgan Chase. On the other hand, investors looking for exposure to the financial services market might find Citi a compelling rebound play.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs